Myeloid neoplasm
MONDO:0005170Proliferation of myeloid cells originating from a primitive stem cell.
Also known as: myeloid malignancy, myeloid neoplasm, myeloid tumor, myeloid tumour
4465 clinical trials for this condition and its sub-types, 48 tagged with Myeloid neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Myeloid neoplasm
-
Myeloproliferative neoplasm 166 trials · 1,632 incl. sub-types
13 sub-types
- Myeloid leukemia 30 trials · 1,334 incl. sub-types Sub-types →
- Myelodysplastic/myeloproliferative neoplasm 81 trials · 234 incl. sub-types Sub-types →
- Primary myelofibrosis 191 trials · 195 incl. sub-types Sub-types →
- Myelofibrosis 149 trials
- Erythroid neoplasm 0 trials · 95 incl. sub-types Sub-types →
- Essential thrombocythemia 67 trials
- Therapy-related myeloid neoplasm 54 trials
- Myeloproliferative neoplasm, unclassifiable 11 trials · 16 incl. sub-types Sub-types →
- Transient myeloproliferative syndrome 13 trials
- Chronic neutrophilic leukemia 10 trials
- Chronic eosinophilic leukemia 9 trials
- Myeloproliferative disease, autosomal recessive 0 trials
- Thrombocytopenia 6 0 trials
-
Plasma cell myeloma 1,108 trials · 1,131 incl. sub-types
3 sub-types
- Smoldering plasma cell myeloma 63 trials · 64 incl. sub-types Sub-types →
- Non-secretory plasma cell myeloma 1 trial
- Osteosclerotic plasma cell myeloma 0 trials
-
Mast cell neoplasm 0 trials · 34 incl. sub-types
2 sub-types
- Mastocytosis 15 trials · 34 incl. sub-types Sub-types →
- Mastocytoma 0 trials Sub-types →
-
CD4+/CD56+ hematodermic neoplasm 31 trials
Most studied deeper sub-types
-
Promising combo for IDH1 leukemia hits early snag – trial stopped
Disease control Stopped earlyThis early-phase trial tested whether adding the targeted drug ivosidenib to standard FLAG chemotherapy could help people with a specific genetic form of acute myeloid leukemia (IDH1-mutant AML). The study aimed to find the best dose and check for side effects in patients whose c…
Phase 1 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Stem cell transplant study halted early: which prep works best?
Disease control Stopped earlyThis study tested two different drug combinations given before a stem cell transplant for people with myeloid blood cancers like leukemia. One group got fludarabine and busulfan, the other got those drugs plus low-dose total body irradiation. The goal was to see which regimen led…
Phase 3 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Cancer drug trial halted early – what happened?
Disease control Stopped earlyThis phase 2 trial tested the drug futibatinib in 115 people with advanced solid tumors or blood cancers that have specific FGFR gene changes. The goal was to see if the drug could shrink tumors or cause remission. The study was terminated early, so final results are not yet clea…
Phase 2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for kids after transplant: study tests safer GVHD prevention
Disease control Stopped earlyThis study looked at a new way to prevent severe graft-versus-host disease (GVHD) in children who had a bone marrow transplant for blood cancers. The goal was to see if stopping certain immune-suppressing drugs after day 60 could lower the risk of severe GVHD. Only 3 children too…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC